Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer. | Sci Rep | 2023 | 36890266 | PubTator, text mining | PubMed |
| Protective effect of bone marrow mesenchymal stem cell-derived exosomes on cardiomyoblast hypoxia-reperfusion injury through the HAND2-AS1/miR-17-5p/Mfn2 axis. | BMC Cardiovasc Disord | 2023 | 36882677 | PubTator, text mining | PubMed |
| LncRNA and its role in gastric cancer immunotherapy. | Front Cell Dev Biol | 2023 | 36875764 | PubTator, text mining | PubMed |
| Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. | Sci Rep | 2023 | 36871072 | PubTator, text mining | PubMed |
| SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells. | Diagn Pathol | 2023 | 36864456 | PubTator, text mining | PubMed |
| Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6. | Cell Transplant | 2023 | 36852700 | PubTator, text mining | PubMed |
| Metformin and long non-coding RNAs in breast cancer. | J Transl Med | 2023 | 36849958 | PubTator, text mining | PubMed |
| Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma. | BMC Genomics | 2023 | 36849926 | PubTator, text mining | PubMed |
| Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review. | Transl Oncol | 2023 | 36841158 | PubTator, text mining | PubMed |
| Nanomedicine for Combination Urologic Cancer Immunotherapy. | Pharmaceutics | 2023 | 36839868 | PubTator, text mining | PubMed |
| Exosomes: The Role in Tumor Tolerance and the Potential Strategy for Tumor Therapy. | Pharmaceutics | 2023 | 36839784 | PubTator, text mining | PubMed |
| Exosomes as a Source of Biomarkers for Gastrointestinal Cancers. | Cancers (Basel) | 2023 | 36831603 | PubTator, text mining | PubMed |
| LncRNA LINC01094 Promotes Cells Proliferation and Metastasis through the PTEN/AKT Pathway by Targeting AZGP1 in Gastric Cancer. | Cancers (Basel) | 2023 | 36831602 | PubTator, text mining | PubMed |
| Noncoding RNAs Controlling Oxidative Stress in Cancer. | Cancers (Basel) | 2023 | 36831498 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. | Cancers (Basel) | 2023 | 36831450 | PubTator, text mining | PubMed |
| The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer. | Cancers (Basel) | 2023 | 36831352 | PubTator, text mining | PubMed |
| Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer. | Cells | 2023 | 36831341 | PubTator, text mining | PubMed |
| Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease. | Antioxidants (Basel) | 2023 | 36829822 | PubTator, text mining | PubMed |
| Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma. | Biology (Basel) | 2023 | 36829596 | PubTator, text mining | PubMed |
| A Comprehensive Review of Mammalian Pigmentation: Paving the Way for Innovative Hair Colour-Changing Cosmetics. | Biology (Basel) | 2023 | 36829566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=23